-The Hindu Are differences within the middle class, in income, education, and cultural and social capital, so wide as to render moot any ideological or behavioural coherence to this group? The rapid growth of the Indian economy over the past three decades has led to a substantial expansion of India's "middle class". This has triggered a robust debate over who in India actually belongs to the "middle class," its size, composition, and...

-FAO Spotlight turns to humanity's silent ally and the risks it faces Rome: Healthy soils are critical for global food production, but we are not paying enough attention to this Important "silent ally," FAO Director-General José Graziano da Silva said on the eve of World Soil Day, to be celebrated on 5 December. Healthy soils not only are the foundation for food, fuel, fibre and medical products, but also are essential to...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-The Telegraph New Delhi: Bengal appears to have emerged as one of the best performers in implementing the rural job scheme, rising to fourth on the list from being one of the laggards even two years back. According to figures with the rural development ministry, the state has generated over 11.3 crore persondays of work since April, next only to table-topper Tamil Nadu, Andhra Pradesh and Rajasthan. Till 2012, it was among the...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...